Objective Numerous studies have assessed the association between Nonalcoholic fatty liver
disease (NAFLD) and cardiovascular disease (CVD). However, results have been conflicting …

Aims Metabolic syndrome increases the risk of chronic diseases including cardiovascular
diseases and diabetes. The present study investigated the prevalence of metabolic …

Methods Embase and Medline were searched for articles relating to NAFLD, carotid
atherosclerosis, and stroke. Proportional data was analysed using a generalized linear …

Nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of
atherosclerotic cardiovascular disease. In our meta‐analysis, we aimed to assess the …

Background & aims The beneficial effect of genistein has indicated on metabolic disorders
and inflammatory state. The aim of this study was to investigate the effect of genistein …

Context: Non-alcoholic fatty liver disease (NAFLD) is progressing considerably worldwide.
Identifying the risk factors of NAFLD is a critical step in preventing its progression. Methods …

Background Non-alcoholic fatty liver disease (NAFLD) is a well-established risk factor for
cardiovascular disease, with ethnic and regional differences noted. With the recent surge of …

Background and aim The aim of this study was to describe the frequency of non-alcoholic
fatty liver disease (NAFLD) in patients with diabetes mellitus (DM), hyperlipidemia, obesity …

Background In patients with NAFLD, there is an increased risk of cardiovascular disease
(CVD). Selenoprotein P (SelP), a hepatokine, is associated with insulin resistance (IR) and …

Nonalcoholic fatty liver disease (NAFLD) is considered a potential independent risk factor for
cardiovascular disease (CVD). The Multi-Ethnic Study of Atherosclerosis cohort enrolled …